Implementing a Standardized Social Networks Testing Strategy in a Low HIV Prevalence Jurisdiction.


Journal

AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 17 5 2018
medline: 8 5 2019
entrez: 17 5 2018
Statut: ppublish

Résumé

Alternative HIV testing strategies are needed to engage individuals not reached by traditional clinical or non-clinical testing programs. A social networks recruitment strategy, in which people at risk for or living with HIV are enlisted and trained by community-based agencies to recruit individuals from their social, sexual, or drug-using networks for HIV testing, demonstrates higher positivity rates compared to other non-clinical recruitment strategies in some jurisdictions. During 2013-2015, a social networks testing protocol was implemented in Wisconsin to standardize an existing social networks testing program. Six community-based, non-clinical agencies with multiple sites throughout the state implemented the protocol over the 2-year period. Both quantitative and qualitative data were collected. The new positivity rate (0.49%) through social networks testing did not differ from that of traditional counseling, testing, and referral recruitment methods (0.48%). Although social networks testing did not yield a higher new positivity rate compared to other testing strategies, it proved to be successful at reaching high risk individuals who may not otherwise engage in HIV testing.

Identifiants

pubmed: 29766328
doi: 10.1007/s10461-018-2146-x
pii: 10.1007/s10461-018-2146-x
pmc: PMC6249107
mid: NIHMS995221
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

41-47

Subventions

Organisme : NIDA NIH HHS
ID : K23 DA032306
Pays : United States
Organisme : NCHHSTP CDC HHS
ID : U62 PS003668
Pays : United States
Organisme : Health Resources and Services Administration
ID : H97HA22698
Organisme : National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
ID : NU62PS003668-05-02

Références

AIDS. 2006 Oct 3;20(15):1961-8
pubmed: 16988518
Am J Public Health. 2009 Jun;99(6):1093-9
pubmed: 19372521
Am J Public Health. 2010 Apr 1;100 Suppl 1:S5-6; author reply S6
pubmed: 20147665
Ann Behav Med. 2011 Dec;42(3):361-9
pubmed: 21818527
Health Educ Behav. 2013 Feb;40(1):32-41
pubmed: 22505573
AIDS Educ Prev. 2013 Jun;25(3):190-202
pubmed: 23631714
Am J Public Health. 2013 Oct;103(10):1851-6
pubmed: 23948017
AIDS Care. 2014;26(5):608-12
pubmed: 24116886
Am J Public Health. 2015 Feb;105(2):e75-82
pubmed: 25521875
JAMA Intern Med. 2015 Apr;175(4):588-96
pubmed: 25706928
AIDS Behav. 2017 Mar;21(3):619-625
pubmed: 27624729

Auteurs

Casey Schumann (C)

AIDS/HIV Program, Division of Public Health, Wisconsin Department of Health Services, Madison, WI, USA. caseyschumann@yahoo.com.

Danielle Kahn (D)

Division of Infectious Diseases, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Michelle Broaddus (M)

Center for AIDS Intervention Research, Medical College of Wisconsin, Milwaukee, WI, USA.

Jacob Dougherty (J)

AIDS/HIV Program, Division of Public Health, Wisconsin Department of Health Services, Madison, WI, USA.

Megan Elderbrook (M)

AIDS/HIV Program, Division of Public Health, Wisconsin Department of Health Services, Madison, WI, USA.

James Vergeront (J)

AIDS/HIV Program, Division of Public Health, Wisconsin Department of Health Services, Madison, WI, USA.

Ryan Westergaard (R)

Division of Infectious Diseases, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH